HEADER SIGNALING PROTEIN 13-FEB-07 2ECD TITLE SOLUTION STRUCTURE OF THE HUMAN ABL2 SH2 DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SH2 DOMAIN; COMPND 5 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 2, ABELSON- COMPND 6 RELATED GENE PROTEIN, TYROSINE KINASE ARG; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL2; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P040705-09; SOURCE 8 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS KEYWDS SH2 DOMAIN, PHOSPHOTYROSINE BINDING DOMAIN, PROTEIN TYROSINE KINASE, KEYWDS 2 SIGNAL TRANSDUCTION, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT KEYWDS 3 ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL KEYWDS 4 GENOMICS/PROTEOMICS INITIATIVE, RSGI, SIGNALING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.KASAI,S.KOSHIBA,M.INOUE,T.KIGAWA,S.YOKOYAMA,RIKEN STRUCTURAL AUTHOR 2 GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 4 29-MAY-24 2ECD 1 REMARK REVDAT 3 09-MAR-22 2ECD 1 REMARK SEQADV REVDAT 2 24-FEB-09 2ECD 1 VERSN REVDAT 1 19-FEB-08 2ECD 0 JRNL AUTH T.KASAI,S.KOSHIBA,M.INOUE,T.KIGAWA,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE HUMAN ABL2 SH2 DOMAIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.5, CYANA 2.0.17 REMARK 3 AUTHORS : BRUKER (XWINNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ECD COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000026493. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.33MM SH2 DOMAIN U-15N, 13C; REMARK 210 20MM D-TRIS-HCL(PH 7.0); 100MM REMARK 210 NACL; 1MM D-DTT; 0.02% NAN3; 90% REMARK 210 H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20031121, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9810, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS, REMARK 210 RESTRAINTED MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, STRUCTURES REMARK 210 WITH THE LOWEST ENERGY, TARGET REMARK 210 FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 5 110.43 -172.29 REMARK 500 1 LYS A 15 -62.16 -90.86 REMARK 500 1 HIS A 16 142.44 -34.51 REMARK 500 1 SER A 34 35.05 -90.67 REMARK 500 1 ASN A 37 43.65 -84.66 REMARK 500 1 SER A 47 -70.99 -40.62 REMARK 500 1 VAL A 77 74.98 -106.35 REMARK 500 1 LEU A 100 173.05 -48.45 REMARK 500 1 LEU A 104 101.57 -47.02 REMARK 500 1 LYS A 110 47.01 31.92 REMARK 500 1 SER A 118 135.92 -171.81 REMARK 500 2 ASN A 11 132.66 -170.43 REMARK 500 2 HIS A 20 40.65 -107.20 REMARK 500 2 SER A 34 34.44 -87.68 REMARK 500 2 ILE A 36 177.36 -52.34 REMARK 500 2 ASN A 37 44.51 -85.25 REMARK 500 2 PRO A 49 86.98 -69.82 REMARK 500 2 TYR A 76 122.03 -171.32 REMARK 500 2 LEU A 100 -178.83 -53.03 REMARK 500 2 PRO A 107 -164.63 -69.77 REMARK 500 3 VAL A 10 36.31 37.76 REMARK 500 3 LEU A 13 43.19 -86.68 REMARK 500 3 GLU A 14 48.02 -75.73 REMARK 500 3 HIS A 20 -51.83 -124.18 REMARK 500 3 PRO A 22 86.64 -69.65 REMARK 500 3 LEU A 35 173.64 -59.42 REMARK 500 3 GLU A 46 -70.46 -85.40 REMARK 500 3 SER A 48 162.78 -41.48 REMARK 500 3 PRO A 49 -162.91 -69.80 REMARK 500 3 GLU A 59 96.78 -38.45 REMARK 500 3 THR A 78 148.72 -176.65 REMARK 500 3 HIS A 93 33.67 -83.98 REMARK 500 3 ASP A 98 83.01 -54.82 REMARK 500 4 ASN A 11 140.64 -35.63 REMARK 500 4 LEU A 13 57.50 -112.14 REMARK 500 4 TYR A 19 88.73 -68.23 REMARK 500 4 PRO A 22 82.86 -69.70 REMARK 500 4 LEU A 35 -178.60 -59.71 REMARK 500 4 PRO A 49 8.96 -69.87 REMARK 500 4 TYR A 76 122.45 -173.06 REMARK 500 4 VAL A 77 76.16 -105.51 REMARK 500 4 VAL A 101 -36.78 -33.82 REMARK 500 4 THR A 102 149.64 -173.76 REMARK 500 4 PRO A 107 -177.42 -69.84 REMARK 500 4 SER A 117 123.36 -36.26 REMARK 500 5 SER A 12 96.19 -51.35 REMARK 500 5 GLU A 14 83.03 -55.93 REMARK 500 5 PRO A 22 93.90 -69.78 REMARK 500 5 ILE A 36 162.09 -49.20 REMARK 500 5 PRO A 49 87.58 -69.80 REMARK 500 REMARK 500 THIS ENTRY HAS 278 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSS001001181.1 RELATED DB: TARGETDB DBREF 2ECD A 8 113 UNP P42684 ABL2_HUMAN 163 268 SEQADV 2ECD GLY A 1 UNP P42684 EXPRESSION TAG SEQADV 2ECD SER A 2 UNP P42684 EXPRESSION TAG SEQADV 2ECD SER A 3 UNP P42684 EXPRESSION TAG SEQADV 2ECD GLY A 4 UNP P42684 EXPRESSION TAG SEQADV 2ECD SER A 5 UNP P42684 EXPRESSION TAG SEQADV 2ECD SER A 6 UNP P42684 EXPRESSION TAG SEQADV 2ECD GLY A 7 UNP P42684 EXPRESSION TAG SEQADV 2ECD SER A 114 UNP P42684 EXPRESSION TAG SEQADV 2ECD GLY A 115 UNP P42684 EXPRESSION TAG SEQADV 2ECD PRO A 116 UNP P42684 EXPRESSION TAG SEQADV 2ECD SER A 117 UNP P42684 EXPRESSION TAG SEQADV 2ECD SER A 118 UNP P42684 EXPRESSION TAG SEQADV 2ECD GLY A 119 UNP P42684 EXPRESSION TAG SEQRES 1 A 119 GLY SER SER GLY SER SER GLY THR PRO VAL ASN SER LEU SEQRES 2 A 119 GLU LYS HIS SER TRP TYR HIS GLY PRO VAL SER ARG SER SEQRES 3 A 119 ALA ALA GLU TYR LEU LEU SER SER LEU ILE ASN GLY SER SEQRES 4 A 119 PHE LEU VAL ARG GLU SER GLU SER SER PRO GLY GLN LEU SEQRES 5 A 119 SER ILE SER LEU ARG TYR GLU GLY ARG VAL TYR HIS TYR SEQRES 6 A 119 ARG ILE ASN THR THR ALA ASP GLY LYS VAL TYR VAL THR SEQRES 7 A 119 ALA GLU SER ARG PHE SER THR LEU ALA GLU LEU VAL HIS SEQRES 8 A 119 HIS HIS SER THR VAL ALA ASP GLY LEU VAL THR THR LEU SEQRES 9 A 119 HIS TYR PRO ALA PRO LYS CYS ASN LYS SER GLY PRO SER SEQRES 10 A 119 SER GLY HELIX 1 1 SER A 24 SER A 34 1 11 HELIX 2 2 THR A 85 VAL A 96 1 12 SHEET 1 A 4 TYR A 19 PRO A 22 0 SHEET 2 A 4 PHE A 40 SER A 45 1 O VAL A 42 N HIS A 20 SHEET 3 A 4 GLN A 51 ARG A 57 -1 O GLN A 51 N SER A 45 SHEET 4 A 4 VAL A 62 TYR A 65 -1 O TYR A 63 N LEU A 56 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 MODEL 6 MODEL 7 MODEL 8 MODEL 9 MODEL 10 MODEL 11 MODEL 12 MODEL 13 MODEL 14 MODEL 15 MODEL 16 MODEL 17 MODEL 18 MODEL 19 MODEL 20